HomeBusinessHealthcare Industry Stock NewsPres. Biden & Sen. Sanders Pen Op-Ed Criticizing Weight Loss & Diabetes Drug Prices

Pres. Biden & Sen. Sanders Pen Op-Ed Criticizing Weight Loss & Diabetes Drug Prices

President Biden and Senator Sanders pen an op-ed criticizing weight loss and diabetes drug prices. Caroline Woods talks about what this means for weight loss stocks like Eli Lilly (LLY). She talks about how the op-ed mentions that Big Pharma will claim that reducing prices would drive down innovation, but that may not be the case.

Next Gen Investing

02 Jul 2024

SHARE

ON AIR
education
10:00 pm
Inside the Mind of a Trader
replay
12:00 am
Trading 360
REPLAY
1:00 am
Fast Market
REPLAY
2:00 am
Next Gen Investing
REPLAY
3:00 am
Market Overtime
REPLAY
3:30 am
Market Overtime
REPLAY
education
4:00 am
Your First Trade
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Inside the Mind of a Trader
REPLAY
6:00 am
Market Overtime
REPLAY
6:30 am
Market Overtime
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Trading 360
REPLAY
9:00 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
ON AIR
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor